local_hospital

Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino

Address
lock Available on a paid plan

Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino

The Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino is a leading Italian academic medical center engaged in advanced cardiovascular research. The institution demonstrates particular expertise in investigating innovative therapeutic approaches for severe cardiac inflammatory conditions, focusing on critical care interventions for patients with life-threatening cardiac emergencies.

  • Acute myocarditis management and treatment protocols
  • High-dose corticosteroid therapy in cardiovascular emergencies
  • Cardiac inflammation and fulminant cardiac conditions

The center's research program emphasizes the development of evidence-based interventions for complicated and fulminant acute myocarditis, evaluating novel therapeutic strategies including high-dose pulse intravenous corticosteroid therapy. Their clinical trials aim to establish more effective treatment protocols for patients with severe cardiac inflammation, combining innovative pharmacological approaches with maximal supportive care to improve patient outcomes in critical cardiac conditions.

Site Overview

assignment
6
connected trials
corporate_fare
5
sponsors
science
29
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
6
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 of 5 therapeutic areas and 15 of 29 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
5
Sponsors (total)
5
Active sponsors
4

Sponsor Network

Top 4 by active trials.

lock +3 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 566 other sites in Italy

description
Trial volume
6
Outperforms 62% of sites
public
Therapeutic diversity
5areas
Outperforms 71% of sites
groups
Sponsor diversity
5sponsors
Outperforms 61% of sites

Therapeutic Area Benchmark — Italy

Select a therapeutic area to compare against other sites in Italy.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Italy

Market Share

Country: Italy

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino

lock Showing 1 of 6 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Conservative Versus Conventional Oxygen Administration on ICU Mortality in Mechanically Ventilated Critically Ill Adults Using Nitrous Oxide and OxygenAzienda Ospedaliero Universitaria Di ModenaPhase IIIRecruitingDec 2024

IMP list

lock Showing 1 of 29 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Acetylsalicylic Acid1Unknown2024-12-162024-12-16

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.